Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
20 News Items found
In the Clinic
Medical oncologist Jae Park
Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

The study represents 20 years of research at MSK.
In the News
Gears with 2016 and 2017
Year in Review: The Science and Technology that Shaped Cancer Care in 2017

As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
Announcement
Pediatric oncologist Kevin Curran with CAR T patient Esmeralda Pineda
FDA Approves First CAR T Cell Therapy for Leukemia

Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.
Feature
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Three Compelling Cancer Advances from 2015

MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
In the Clinic
CAR T cell therapy
CAR T Cell Therapies Are a Growing Area of Research

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
In the Clinic
Pictured: Serge Lyashchenko
How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.
In the Clinic
New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.
In the Clinic
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
In the Clinic
Pictured: Isabelle Rivière and Michel Sadelain
Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.
In the Clinic
Pictured: Michael Morris
Bone Scan Index May Help Determine Response to Prostate Cancer Treatment

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.